- ASSOCIATE PROFESSOR Radiation Oncology
MBBCH, University of Witwatersrand
Residency, Internal Medicine
Mount Sinai Hospital
Residency, Radiation Oncology
Mount Sinai Hospital
- I am a radiation oncologist whose clinical practice is dedicated to the treatment of patients with breast cancer. My colleagues and I offer breast cancer treatment using state of the art radiation treatment techniques, customized to each individual, focusing on optimizing treatment outcomes while minimizing any normal tissue toxicity. I am also the co-director of the Stereotactic Radiosurgery Program at Mount Sinai Hospital, which focuses on the non- invasive delivery of highly targeted radiation therapy for management of tumors of the brain and/or spine (both benign and malignant).
My clinical research is focused on optimizing the quality of life of patients undergoing breast cancer radiation therapy. Together with my psychologist colleagues, we have completed several studies evaluating factors which negatively impact quality of life (QOL) and have successfully developed and implemented specific interventions to minimize or prevent a decrease in QOL.
I am a member of several professional organizations including The American Society for Therapeutic Radiation and Oncology, The American College of Radiology and The American Society of Breast Diseases.
America's Top Oncologists
Recognition of Excellence in Teaching Award
The Institute for Medical Education of the Mount Sinai School of Medicine
Teacher of the Year Award
Association of Residents in Radiation Oncology
Community Education Award
American Cancer Society
Montgomery GH, David D, Kangas M, Green S, Sucala M, Bovbjerg DH, Hallquist MN, Schnur JB. Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Feb; 32(6).
Lehrer S, Green S, Ramanathan L, Rosenzweig KE. Insufficient sleep associated with increased breast cancer mortality. Sleep medicine 2013 May; 14(5).
Lehrer S, Green S, Ramanathan L, Rosenzweig KE. Obesity and deranged sleep are independently associated with increased cancer mortality in 50 US states and the District of Columbia. Sleep & breathing = Schlaf & Atmung 2013 Sep; 17(3).
Mccormick PJ, Osborn IP, Germano IM, Green S, Deiner SG. Scalp nerve blockade reduces pain after headframe placement in radiosurgery: a double blind, randomized clinical trial. Middle East journal of anaesthesiology 2013 Feb; 22(1).
Schnur JB, Graff Zivin J, Mattson DM, Green S, Jandorf LH, Wernicke AG, Montgomery GH. Acute skin toxicity-related, out-of-pocket expenses in patients with breast cancer treated with external beam radiotherapy: a descriptive, exploratory study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012 Dec; 20(12).
Lehrer S, Green S, Stock RG. Association between number of cell phone contracts and brain tumor incidence in nineteen U.S. States. Journal of neuro-oncology 2011 Feb; 101(3).
Schnur JB, Love B, Scheckner BL, Green S, Wernicke AG, Gabriella A, Montgomery GH. A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy. American journal of clinical oncology 2011 Oct; 34(5).
Schnur JB, Ouellette SC, Dilorenzo TA, Green S, Montgomery GH. A qualitative analysis of acute skin toxicity among breast cancer radiotherapy patients. Psycho-oncology 2011 Mar; 20(3).
Montgomery GH, Kangas M, David D, Hallquist MN, Green S, Bovbjerg DH, Schnur JB. Fatigue during breast cancer radiotherapy: an initial randomized study of cognitive-behavioral therapy plus hypnosis. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2009 May; 28(3).
Schnur JB, David D, Kangas M, Green S, Bovbjerg DH, Montgomery GH. A randomized trial of a cognitive-behavioral therapy and hypnosis intervention on positive and negative affect during breast cancer radiotherapy. Journal of clinical psychology 2009 Apr; 65(4).
Ho AY, Atencio DP, Peters S, Stock RG, Formenti SC, Cesaretti JA, Green S, Haffty B, Drumea K, Leitzin L, Kuten A, Azria D, Ozsahin M, Overgaard J, Andreassen CN, Trop CS, Park J, Rosenstein BS. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. International journal of radiation oncology, biology, physics 2006 Jul; 65(3).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Green did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
1184 Fifth Avenue, 1st Floor
New York, NY 10029
- Monday 9:00am - 5:00pm
- Tuesday 9:00am - 5:00pm
- Wednesday 9:00am - 5:00pm
- Thursday 9:00am - 5:00pm
- Friday 9:00am - 5:00pm
- 1199 National Benefit Fund
- 32B-J Building Service
- Aetna Managed Choice
- Aetna Open Choice
- Aetna Select Choice
- Aetna U.S. Healthcare
- Aetna U.S. Healthcare - HMO
- Anthem Health
- Atlantis Health Plan
- Beech Street
- CHAMPUS (Tri-care)
- CIGNA Healthcare HMO
- Cigna - PPO
- Devon Health Services
- Emblem Health
- Empire Blue Cross/Blue Shield
- First Health
- GHI HMO
- Group Health Insurance (GHI) - PPO
- Group Health Insurance, Inc.
- HIP Medicaid
- Health Insurance Plan (HIP)
- HealthFirst/Medicaid HMO
- HealthPlus, Inc.
- Healthnet/PHS/Guardian - PPO
- Island Group
- MedCare International
- Medicare Assignment
- Mount Sinai Health Systems
- MultiPlan, Inc.
- Neighborhood Health Providers, LLC
- Oxford Freedom
- Oxford Liberty
- Physicians Health Services
- Prem Preferred Care/Beechstreet
- Private Healthcare Systems (PHCS)
- Prudential Healthcare: a member company of Aetna
- Railroad Medicare
- Travel Care Services
- United Health Care - Mount Sinai Top Tier
- United Health Care Empire Plan
- United Healthcare
- United Healthcare Medicare
- United Payors and United Providers
- VNS Medicare
- WellCare of New York, Inc.
- Workers' Compensation
- Master Card
- American Express
- Personal Check